Panbela Therapeutics, Inc.

The momentum for this stock is not very good. Panbela Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Panbela Therapeutics, Inc..

News

Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results

Globe Newswire MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet...\n more…

Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024

Globe Newswire MINNEAPOLIS, March 12, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), ( Panbela ), a clinical stage company developing disruptive therapeutics for the treatment of patients...\n more…

Panbela Therapeutics regains compliance with Nasdaq

SeekingAlpha.com: All News Panbela Therapeutics (PBLA) regains compliance with Nasdaq for bid price and publicly held shares, marking a positive development for the clinical stage...\n more…

Panbela Therapeutics regains compliance with Nasdaq listing standards

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements

Globe Newswire MINNEAPOLIS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), ( Panbela ), a clinical stage company developing disruptive therapeutics for the treatment of patients with...\n more…

Panbela Therapeutics (NASDAQ:PBLA) vs. NeuroSense Therapeutics (NASDAQ:NRSN) Head to Head Contrast

Zolmax Panbela Therapeutics (NASDAQ:PBLA Get Free Report) and NeuroSense Therapeutics (NASDAQ:NRSN Get Free Report) are both medical companies, but which is the better investment? We will...\n more…